doxepin hydrochloride

DRUG3 trials

Sponsors

Medical University Of Graz, Alliance for Clinical Trials in Oncology, Mayo Clinic

Conditions

Esophageal CarcinomaHead and Neck CancerHypopharyngeal CarcinomaLaryngeal CarcinomaLymphomaMesotheliomaMetastatic Malignant Neoplasm in the LungMetastatic Malignant Neoplasm in the Pleura

Phase 1

A single center, randomized, controlled trial in healthy volunteers using dermal open flow microperfusion to assess cutaneous BE of two doxepin hydrochloride creams

Not yet recruitingCTIS2026-526078-18-00

Medical University Of GrazNo medical condition is being investigated in this clinical trial.

Target: 24Updated: 2026-07-17

Phase 2

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

TerminatedNCT02062632

Mayo ClinicEsophageal Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma +11

Start: 2014-04-14End: 2017-11-06Updated: 2019-10-01

Phase 3

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

CompletedNCT01156142

Alliance for Clinical Trials in OncologyHead and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy +1

Start: 2010-12-31End: 2015-03-02Updated: 2017-08-09